A citation-based method for searching scientific literature

Isabel E Wassing, Fumiko Esashi. Semin Cell Dev Biol 2021
Times Cited: 3







List of co-cited articles
5 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2.
Fumiko Esashi, Vitold E Galkin, Xiong Yu, Edward H Egelman, Stephen C West. Nat Struct Mol Biol 2007
185
66

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
719
66

TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity.
Pavel Moudry, Kenji Watanabe, Kamila M Wolanin, Jirina Bartkova, Isabel E Wassing, Sugiko Watanabe, Robert Strauss, Rune Troelsgaard Pedersen, Vibe H Oestergaard, Michael Lisby,[...]. J Cell Biol 2016
41
66

BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability.
Keiko Yata, Jean-Yves Bleuyard, Ryuichiro Nakato, Christine Ralf, Yuki Katou, Rebekka A Schwab, Wojciech Niedzwiedz, Katsuhiko Shirahige, Fumiko Esashi. Cell Rep 2014
38
66

Plk1 and CK2 act in concert to regulate Rad51 during DNA double strand break repair.
Keiko Yata, Janette Lloyd, Sarah Maslen, Jean-Yves Bleuyard, Mark Skehel, Stephen J Smerdon, Fumiko Esashi. Mol Cell 2012
108
66



Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies.
Anna Minchom, Caterina Aversa, Juanita Lopez. Ther Adv Med Oncol 2018
61
33

Biomarker-Guided Development of DNA Repair Inhibitors.
James M Cleary, Andrew J Aguirre, Geoffrey I Shapiro, Alan D D'Andrea. Mol Cell 2020
43
33

Endogenous DNA double-strand breaks: production, fidelity of repair, and induction of cancer.
Michael M Vilenchik, Alfred G Knudson. Proc Natl Acad Sci U S A 2003
418
33

Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability.
Hauke Cornils, Reto S Kohler, Alexander Hergovich, Brian A Hemmings. Mol Cell Biol 2011
83
33

Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Felix Dietlein, Lisa Thelen, H Christian Reinhardt. Trends Genet 2014
158
33

A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.
Cecilia Cotta-Ramusino, E Robert McDonald, Kristen Hurov, Mathew E Sowa, J Wade Harper, Stephen J Elledge. Science 2011
141
33

State-of-the-art strategies for targeting the DNA damage response in cancer.
Patrick G Pilié, Chad Tang, Gordon B Mills, Timothy A Yap. Nat Rev Clin Oncol 2019
315
33

DNA damage and the balance between survival and death in cancer biology.
Wynand P Roos, Adam D Thomas, Bernd Kaina. Nat Rev Cancer 2016
520
33


Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors.
Christopher J Lord, Andrew N J Tutt, Alan Ashworth. Annu Rev Med 2015
289
33

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.
Nuala McCabe, Nicholas C Turner, Christopher J Lord, Katarzyna Kluzek, Aneta Bialkowska, Sally Swift, Sabrina Giavara, Mark J O'Connor, Andrew N Tutt, Małgorzata Z Zdzienicka,[...]. Cancer Res 2006
831
33

NDR Kinases Are Essential for Somitogenesis and Cardiac Looping during Mouse Embryonic Development.
Debora Schmitz-Rohmer, Simone Probst, Zhong-Zhou Yang, Frédéric Laurent, Michael B Stadler, Aimée Zuniga, Rolf Zeller, Debby Hynx, Brian A Hemmings, Alexander Hergovich. PLoS One 2015
15
33

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Win Topatana, Sarun Juengpanich, Shijie Li, Jiasheng Cao, Jiahao Hu, Jiyoung Lee, Kenneth Suliyanto, Diana Ma, Bin Zhang, Mingyu Chen,[...]. J Hematol Oncol 2020
17
33

MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.
Ramazan Gundogdu, Alexander Hergovich. Cells 2019
18
33

PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers.
Patrick G Pilié, Carl M Gay, Lauren A Byers, Mark J O'Connor, Timothy A Yap. Clin Cancer Res 2019
115
33

Biomarkers of Response and Resistance to DNA Repair Targeted Therapies.
Elizabeth H Stover, Panagiotis A Konstantinopoulos, Ursula A Matulonis, Elizabeth M Swisher. Clin Cancer Res 2016
82
33

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models.
Claudia Winkler, Joshua Armenia, Gemma N Jones, Luis Tobalina, Matthew J Sale, Tudor Petreus, Tarrion Baird, Violeta Serra, Anderson T Wang, Alan Lau,[...]. Br J Cancer 2021
12
33


Sensing and repairing DNA double-strand breaks.
Stephen P Jackson. Carcinogenesis 2002
804
33

DNA interstrand crosslink repair and cancer.
Andrew J Deans, Stephen C West. Nat Rev Cancer 2011
618
33

Crystal structure of a human Mob1 protein: toward understanding Mob-regulated cell cycle pathways.
Elena S Stavridi, Kimberly G Harris, Yentram Huyen, John Bothos, Peter-Mark Verwoerd, Steve E Stayrook, Nikola P Pavletich, Philip D Jeffrey, Francis C Luca. Structure 2003
57
33

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
33

The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation.
Alexander Hergovich, Reto S Kohler, Debora Schmitz, Anton Vichalkovski, Hauke Cornils, Brian A Hemmings. Curr Biol 2009
87
33

Playing the end game: DNA double-strand break repair pathway choice.
J Ross Chapman, Martin R G Taylor, Simon J Boulton. Mol Cell 2012
958
33

Synthetic lethal therapies for cancer: what's next after PARP inhibitors?
Alan Ashworth, Christopher J Lord. Nat Rev Clin Oncol 2018
163
33


Mob2 Insufficiency Disrupts Neuronal Migration in the Developing Cortex.
Adam C O'Neill, Christina Kyrousi, Melanie Einsiedler, Ingo Burtscher, Micha Drukker, David M Markie, Edwin P Kirk, Magdalena Götz, Stephen P Robertson, Silvia Cappello. Front Cell Neurosci 2018
16
33

Repair of endogenous DNA damage.
T Lindahl, D E Barnes. Cold Spring Harb Symp Quant Biol 2000
337
33

Advances in therapeutic targeting of the DNA damage response in cancer.
Amar Desai, Yan Yan, Stanton L Gerson. DNA Repair (Amst) 2018
29
33

Drosophila Mob family proteins interact with the related tricornered (Trc) and warts (Wts) kinases.
Ying He, Kazuo Emoto, Xiaolan Fang, Nan Ren, Xiaojing Tian, Yuh-Nung Jan, Paul N Adler. Mol Biol Cell 2005
67
33

The DNA-damage response in human biology and disease.
Stephen P Jackson, Jiri Bartek. Nature 2009
33

Regulation of DNA double-strand break repair pathway choice.
Meena Shrivastav, Leyma P De Haro, Jac A Nickoloff. Cell Res 2008
823
33

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.
Britta Stordal, Kirsten Timms, Angela Farrelly, Danielle Gallagher, Steven Busschots, Mickaël Renaud, Julien Thery, Deborah Williams, Jennifer Potter, Thanh Tran,[...]. Mol Oncol 2013
92
33

The rise of covalent proteolysis targeting chimeras.
Ronen Gabizon, Nir London. Curr Opin Chem Biol 2021
9
33

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
929
33

The human tumour suppressor LATS1 is activated by human MOB1 at the membrane.
Alexander Hergovich, Debora Schmitz, Brian A Hemmings. Biochem Biophys Res Commun 2006
127
33

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33


Ablation of the kinase NDR1 predisposes mice to the development of T cell lymphoma.
Hauke Cornils, Mario R Stegert, Alexander Hergovich, Debby Hynx, Debora Schmitz, Stephan Dirnhofer, Brian A Hemmings. Sci Signal 2010
50
33

XRCC3 promotes homology-directed repair of DNA damage in mammalian cells.
A J Pierce, R D Johnson, L H Thompson, M Jasin. Genes Dev 1999
970
33

Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases.
Reto S Kohler, Debora Schmitz, Hauke Cornils, Brian A Hemmings, Alexander Hergovich. Mol Cell Biol 2010
42
33

Regulation of NDR1 activity by PLK1 ensures proper spindle orientation in mitosis.
Maomao Yan, Lingluo Chu, Bo Qin, Zhikai Wang, Xing Liu, Changjiang Jin, Guanglan Zhang, Marta Gomez, Alexander Hergovich, Zhengjun Chen,[...]. Sci Rep 2015
18
33

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor.
Nicholas C Turner, Christopher J Lord, Elizabeth Iorns, Rachel Brough, Sally Swift, Richard Elliott, Sydonia Rayter, Andrew N Tutt, Alan Ashworth. EMBO J 2008
240
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.